Drug and device development is a collaborative process involving input and unique contributions from numerous talented scientists, technicians, and strategists throughout the development process.  Indeed, within the last 10 years the pharmaceutical, biotech, and device industries have come to appreciate that it is virtually impossible for any firm to retain the necessary expertise in all facets of drug and device development to meet their productivity goals alone.  Through partnerships companies extend their pipelines, access new market opportunities, improve clinical and regulatory prospects, and enhance in-house programs. These activities are essential to maximizing commercialization opportunities and driving shareholder value. Partnerships and outsourcing are now a hallmark of the industry and most industry experts expect the steady growth in collaborations and dealmaking to continue for the foreseeable future.

It is this essential activity of every drug and device company that is the focus of our work. We have dedicated our careers to understanding and perfecting the partnering process. In doing so, we have built an industry network that is second to none and strategic, proprietary search and evaluation tools such as the BIOdB that are designed to support the work of business development professionals in all sectors of the industry.   We use these tools and expertise to provide sound strategic, financial, and operational advisory services to a range of customers from small, emerging drug and medtech firms to established multinational pharma and device companies.    Our mission is to deliver specialized knowledge to optimize the business development and strategic transaction process to accelerate value creation for our clients.  There is no mass market in transaction advisory services – we sustain our business through trusted relationships and performance, one client and one engagement at a time.

We invite you to learn how Adjuvant Global Advisors can impact your business. Whether as a strategic advisory client or a BIOdB subscriber, we strive to maximize opportunity and value for our clients and their shareholders.  Contact us as at info@adjuvant.com or call Adjuvant Global Advisors at 703-346-0751. 

Best Regards,

The Founders: Jeff Conroy, Ravi Kiron, and Morrie Ruffin